Wire · opportunities
Will Labcorp's (LH) Digital Trial Upgrades and New Diagnostics Deal Subtly Shift Its Growth ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 5 September 2026 · Fusion42 review
Labcorp announced upgrades to its Global Trial Connect platform and new diagnostic offerings including an Alzheimer’s blood test and renewed reference lab agreement with the U.S. Defense Health Agency. These moves reinforce Labcorp’s position in technology-enabled clinical trials and advanced diagnostics, aiming to boost customer retention and growth amid pricing and reimbursement pressures.
This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure.
◆ ◆ The Wire takeaway
You must prioritise integrating Labcorp’s upgraded trial tech into your biopharma workflows to avoid losing ground as clients demand digital clinical efficiency. The renewed Defence Health Agency deal also opens a stable channel to build long-term revenue beyond common reimbursement risks.
◆ Coverage
1 source · 4 Sep 2026
◆ Related on Wire
◆ Topics